This event is archived. Final snapshot from when the story concluded. View on Dashboard
Regulatory product recall

Abbott Glucose Monitor Recall

Analysis based on 10 articles · First reported Dec 03, 2025 · Last updated Dec 05, 2025

Sentiment
-60
Attention
4
Articles
10
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The recall of glucose monitor sensors by Abbott Laboratories is expected to negatively impact the company's stock price and reputation within the medical device industry. This event highlights regulatory risks for medical device manufacturers and could lead to increased scrutiny and potential legal actions, affecting investor confidence in the sector.

Medical Devices Pharmaceuticals

Abbott Laboratories, through its Abbott Diabetes Care division, has initiated a recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors. The United States — Food and Drug Administration has issued a warning, urging consumers to stop using these devices due to a manufacturing issue that causes incorrect low glucose readings. This malfunction has been linked to 7 deaths worldwide and 736 serious injuries, with 57 injuries reported in the United States. The affected sensors, totaling approximately 3 million units from a single production line, pose significant health risks to people with Diabetes, potentially leading to incorrect treatment decisions such as excessive carbohydrate intake or delayed insulin doses. Abbott Laboratories has stated that the cause of the issue has been identified and resolved, and free replacements are being offered to affected customers.

stock
Abbott Laboratories, through its Abbott Diabetes Care division, is at the center of this event due to the recall of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors. The malfunction has led to serious injuries and deaths, negatively impacting the company's reputation and potentially its stock price.
Importance 100.0 Sentiment -50.0
oth
People with Diabetes are directly affected by the malfunctioning sensors, as incorrect readings can lead to inappropriate treatment decisions, posing serious health risks.
Importance 70.0 Sentiment -20.0
govactor
Importance 0.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.